ABCC6, ACTA2, ACVR1, ADAMTS2, ATP6V0A2, ATP7A, CBS, CHST14, COL11A1, COL1A1, COL1A2, COL2A1, COL3A1, COL5A1, COL5A2, ELN, FBLN5, FBN1, FBN2, FKBP14, MOCS1, MYH11, MYLK, NOTCH1, PKD2, PLOD1, PRDM5, SKI, SLC2A10, SLC39A13, SMAD3, TGFB2, TGFBR1, TGFBR2, TNXB, ZNF469
Connective Tissue Disorders NGS Panel
Connective Tissue Disorders NGS Panel
The Connective Tissue Disorders NGS Panel is a 36-gene panel intended for patients with a diagnosis or clinical suspicion of a connective tissue disorder.
Acromicric dysplasia, Adams-Oliver syndrome, Arterial tortuosity syndrome, Arthrochalasia Ehlers-Danlos syndrome, Brittle cornea syndrome, Congenital contractural arachnodactyly, Cutis laxa, Czech dysplasia\, metatarsal type, Ehlers-Danlos syndrome, Familial bicuspid aortic valve, Familial thoracic aortic aneurysm, Fibrodysplasia ossificans progressiva, Homocystinuria, Loeys-Dietz syndrome, Marfan syndrome, Megacystis-microcolon-intestinal hypoperistalsis syndrome, Menkes disease, Molybdenum cofactor deficiency, Musculocontractural Ehlers-Danlos syndrome, Osteoarthritis with mild chondrodysplasia, Osteogenesis imperfecta, Pseudoxanthoma elasticum, Shprintzen-Goldberg syndrome, Stickler syndrome, Supravalvular aortic stenosis
Clinical Information
This panel consists of 36 genes associated with various forms of connective tissue disorders. Many patients with a suspected connective tissue disorder will present with similar features due to the clinical variability and the variable expressivity among this group of disorders. Making the specific diagnosis can be important in determining the appropriate medical management for features such as aortic dilatation or abnormal wound healing.
Technical Information
This panel is performed by Next Generation Sequencing and covers the coding regions of the listed genes and the flanking intronic sequences. Promoter, 3′ untranslated sequences, and deep intronic sequences are also covered, but only known disease-causing variants in these regions will be reported. Variants identified on the panel are confirmed with Sanger sequencing if they do not meet certain quality thresholds.
Large deletions and duplications (CNVs) affecting the genes of the panel can be detected; however, due to defined settings in the analysis software, CNVs smaller than 2-kb may not be identified (for example, some small exonic level copy number changes may not be identified). Please note that certain types of genetic alterations including trinucleotide repeat expansions, methylation abnormalities, and balanced rearrangements (e.g., inversions, reciprocal translocations) may not be detected by the current analysis.
Specimen Requirements
Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
